Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

Nils Kroeger,Wanling Xie,Jae Lyn Lee,Georg A. Bjarnason,Jennifer J. Knox,Mary J. MacKenzie,Lori Wood,Sandy Srinivas,Ulka N. Vaishamayan,Sun Young Rha,Sumanta K. Pal,Takeshi Yuasa,Frede Donskov,Neeraj Agarwal,Christian Kollmannsberger,Min Han Tan,Scott North,Brian I. Rini,Toni K. Choueiri,Daniel Y. C. Heng

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

2013

Background This study aims to apply the International mRCC Database Consortium (IMDC) Prognostic Model in metastatic non clear cell renal cell carcinoma (nccRCC). Additionally, the survival outcome of metastatic nccRCC patients was characterized.

Keywords:

Pathology
Targeted therapy
Cohort study
Database
Medicine
Clear cell renal cell carcinoma
Survival analysis
overall survival
treatment outcome
prognostic model
survival outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

148

Citations